跳至主要内容
临床试验/NCT05557760
NCT05557760招募中不适用

Evaluating the Effects of Personalized Booster Sessions on Depression Vulnerability Following Cognitive Control Training for Remitted Depressed Individuals

University Ghent2 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2022年10月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
138
试验地点
2
主要终点
Change in Patient Health Questionnaire (PHQ-9)

研究概览

简要总结

The current study aims to examine the impact of booster sessions of cognitive control training (CCT) on indicators of depression vulnerability. Remitted depressed individuals (RMD) will be randomized over two groups, each receiving 10 sessions of the adaptive Paced Auditory Serial Addition Task, a well-established CCT procedure (Koster et al., 2017; Siegle et al., 2007). During and following completion of the training procedure, functioning will be monitored on a weekly basis over a period of 15 weeks. During this period, one group will be offered booster sessions based on early warning signs for possible recurrence of depression, whilst the other group will not receive booster sessions.

详细描述

Cognitive impairments are closely associated with depression and recent studies have found that these cognitive problems can persist following remission of depression. Internet-delivered cognitive control training (CCT), and the adaptive Paced Auditory Serial Addition Task (aPASAT) in particular, has shown to be an effective preventative intervention for remitted depressed individuals (RMD), where beneficial effects have been found for rumination, depressive symptomatology (Hoorelbeke & Koster, 2017), and risk for recurrence of depression (Hoorelbeke et al., 2021). At the same time, prior studies suggest significant heterogeneity in response to CCT, where RMD individuals can show strong fluctuations in functioning in the months following completion of aPASAT training. In line with this, recent findings suggest that, for individuals with high-risk profiles, initial training gains may diminish over time, resulting in recurrence of internalizing symptomatology (Hoorelbeke et al., 2022). As such, there may be merit in the use of CCT booster sessions.

Currently, it is unclear whether offering additional CCT sessions when RMD individuals are reporting increased symptomatology (i.e., adding booster sessions based on early warning signs for possible recurrence of depression) can increase the long-term effectiveness of CCT. In this study, two groups of RMD individuals will perform 10 CCT sessions, after which one group will be offered booster sessions (contingent on indicators of functioning). For this purpose, we will rely on 15 weekly mobile assessments, using the PHQ-9 questionnaire. In addition, functioning will be assessed using a more extensive assessment battery at baseline, post-training (2 weeks after baseline) and follow-up (15 weeks after baseline).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •History of ≥ 1 depressive episode(s)
  • •Currently in remission (≥ 3 months)
  • •Access to a computer with an internet connection
  • •Access to a smartphone

排除标准

  • •Ongoing depressive episode
  • •Psychotic disorder (current and/or previous)
  • •Neurological impairments (current and/or previous)
  • •Excessive substance abuse (current and/or previous)
  • •Use of antidepressant medication is allowed if kept at a constant level

研究组 & 干预措施

Cognitive Control Training Group

Experimental

干预措施: Cognitive Control Training (CCT) (Behavioral)

Cognitive Control Training + Booster Sessions Group

Experimental

干预措施: Cognitive Control Training (CCT) + Booster Sessions (Behavioral)

结局指标

主要结局

Change in Patient Health Questionnaire (PHQ-9)

时间窗: weekly assessments from baseline until follow-up (15 weeks after baseline)

Self-report questionnaire measuring depression symptomatology, with higher scores indicating more severe depression symptoms.

次要结局

  • Change in non-adaptive PASAT performance(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Beck Depression Inventory (BDI-II-NL)(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Adult Temperament Questionnaire (ATQ), Effortful Control subscale(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Remission from Depression Questionnaire (RDQ-NL)(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Short Form Health Survey (SF-36)(baseline, follow-up (15 weeks after baseline))
  • Change in Perseverative Thinking Questionnaire (PTQ-NL)(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Cognitive Emotion Regulation Questionnaire (CERQ)(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Burnout Assessment Tool (BAT)(baseline, post training (2 weeks after baseline), follow-up (15 weeks after baseline))
  • Change in Work Productivity and Activity Impairment Questionnaire (WPAI)(baseline, follow-up (15 weeks after baseline))
  • Change in questionnaire based on the Medical Consumption Questionnaire (iMCQ)(baseline, follow-up (15 weeks after baseline))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验